Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesUrologyAmeriHealth Caritas UroLift Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentAmeriHealth CaritasPolicy CCP.1529

    Prostatic Urethral Lift/UroLift for Benign Prostatic Hyperplasia

    Customize your policy alerts

    Sign up for AmeriHealth Caritas Policy CCP.1529 alerts

    Get alerted when Policy CCP.1529 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage determinations for prostatic urethral lift (UroLift) to treat lower urinary tract symptoms due to benign prostatic hyperplasia. Coverage may be medically necessary when specified prostate-volume and anatomy criteria are met, with case-by-case consideration for selected patients outside the standard criteria.

    Policy Summary
    PayerAmeriHealth Caritas
    PolicyProstatic Urethral Lift/UroLift for Benign Prostatic Hyperplasia
    Policy CodePolicy CCP.1529
    Change TypeMedical necessity criteria revisedreferences updated
    Effective DateAugust 1, 2026
    Last ReviewAug 1, 2026
    Next Review DateNovember 1, 2027
    Key ActionVerify prostate volume, prostate anatomy, and applicable contraindications before determining coverage for UroLift.
    SourceLink
    POLICY UPDATE CHANGES

    In 2025, the medical necessity criteria were revised to align with current American Urological Association recommendations by deleting the age criterion and the requirement for medication failure.

    In 2026, the policy references were updated and the coverage section was identified as modified, although the policy states that no major policy changes were warranted.

    30-80 ccStandard covered prostate-volume range
    No obstructive median lobeRequired standard anatomic criterion

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    >80 to 100 ccCase-by-case prostate-volume range
    >100 ccFDA-listed contraindication
    4Related procedure code groups listed

    Medical Necessity and Coverage Criteria

    Standard medically necessary coverage

    Prostatic urethral lift may be medically necessary for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia when all of the following criteria are met.

    Required standard criteria

    • Clinical indication

      • The member has lower urinary tract symptoms due to benign prostatic hyperplasia.
    • Prostate volume

      • The member has a prostate volume between 30 and 80 cc.30-80 cc
    • Prostate anatomy

      • There is verified absence of an obstructive median lobe of the prostate.No obstructive median lobe

    Case-by-case consideration

    For selected members, the decision to proceed with prostatic urethral lift should be made on a case-by-case basis.

    • Expanded volume or anatomy circumstance

      • The member has a prostate volume greater than 80 cc and up to 100 cc.>80 to 100 cc
      • The member has an obstructive median lobe of the prostate.Obstructive median lobe present
    • Clinical and procedural appropriateness

      • The member is an appropriate candidate for the procedure.

    Contraindications to UroLift include a prostate volume greater than 100 cc, urinary tract infection, urethral conditions that may prevent insertion of the delivery system into the bladder, urinary incontinence, current gross hematuria, and known nickel allergy.

    Related Codes and Prostate Volume Ranges

    Related CPT CodesCPT
    52441Cystourethroscopy, with insertion of permanent adjustable transprostatic implant; single implant.
    +52442Cystourethroscopy, with insertion of permanent adjustable transprostatic implant; each additional permanent adjustable transprostatic implant (List separately in addition to code for primary procedure).
    Related HCPCS CodesHCPCS
    C9739Cystourethroscopy, with insertion of transprostatic implant; one to three implants.
    C9740Cystourethroscopy, with insertion of transprostatic implant; four or more implants
    Standard prostate volume
    Standard prostate volume30 to 80 cc
    Required anatomyVerified absence of an obstructive median lobe of the prostate
    Clinical indicationLower urinary tract symptoms due to benign prostatic hyperplasia
    Case-by-case prostate volume
    Prostate volumeGreater than 80 cc and up to 100 cc
    Coverage determinationThe decision to proceed should be made on a case-by-case basis
    Procedural expertise

    Coverage Determination and Documentation Risks

    Denial Risk

    Confirm eligibility before performing UroLift

    Coverage may be denied when the prostate volume falls outside the covered or case-by-case ranges, when an obstructive median lobe is present without case-by-case review, or when a listed UroLift contraindication exists. For prostate volume greater than 80 cc and up to 100 cc or an obstructive median lobe, proceed only after case-by-case evaluation in an appropriate member by a clinician with sufficient procedural experience and expertise.

    • Standard criteria: prostate volume between 30 and 80 cc and verified absence of an obstructive median lobe.
    • Contraindications include prostate volume greater than 100 cc, urinary tract infection, urethral conditions that may prevent delivery-system insertion into the bladder, urinary incontinence, current gross hematuria, and known nickel allergy.

    Condition and Treatment Background

    Benign prostatic hyperplasia (BPH) is a nonmalignant enlargement of prostate tissue that may cause lower urinary tract symptoms, urinary retention, or infections related to incomplete bladder emptying. Prostatic urethral lift (UroLift) is an endoscopic procedure that uses small metal implants to retract obstructing prostatic lobes and create an open channel through the prostate. It may improve symptoms and urinary flow while generally preserving sexual function; transurethral resection of the prostate may provide greater symptom improvement, and UroLift may have higher retreatment rates.

    Key Terms

    Prostatic urethral lift
    Procedure typeEndoscopic procedure
    Treatment mechanismRetracts obstructing prostatic lobes using small metal implants
    ResultSecures enlarged prostate tissue away from the urethra to create an open channel
    UroLift implant
    Capsular componentNitinol tab
    Urethral componentStainless steel tab
    Connecting componentNon-absorbable suture holds the tabs together
    Policy Summary
    PayerAmeriHealth Caritas
    PolicyProstatic Urethral Lift/UroLift for Benign Prostatic Hyperplasia
    Policy CodePolicy CCP.1529
    Change TypeMedical necessity criteria revisedreferences updated
    Effective DateAugust 1, 2026
    Last ReviewAug 1, 2026
    Next Review DateNovember 1, 2027
    Key ActionVerify prostate volume, prostate anatomy, and applicable contraindications before determining coverage for UroLift.
    SourceLink
    On This Page
    Medical Necessity and Coverage CriteriaRelated Codes and Prostate Volume RangesCoverage Determination and Documentation RisksCondition and Treatment BackgroundKey Terms
    The procedure is performed by a clinician with sufficient procedural experience and expertise.
    The procedure should be performed by clinicians with sufficient procedural experience and expertise
    Contraindicated prostate volume
    Prostate volumeGreater than 100 cc
    Policy statusContraindication to UroLift
    Related contraindicationsUrinary tract infection, urinary incontinence, current gross hematuria, or known nickel allergy
    Benign prostatic hyperplasia
    Full termBenign prostatic hyperplasia
    Also known asBenign prostatic hypertrophy
    DefinitionA nonmalignant growth of prostate tissue